66 entreprises
Accueil > Actualités > Agenda > 2012
2012
Du 31 Janvier au 02 Février 2012 - Conférence BioBusiness
The leading high-level BioPharma strategy and bio-partnering conference
Featured Off-The-Record, PowerPoint-Free Session : 2nd February 2012, 9.40am :
The anatomy of a mega-merger - Analysing the Roche/Genentech fusion two years on
Cast your mind back to March 2009 when Roche announced a $46.8 billion deal to buy Genentech.
Set to the background of an immense global recession and the challenge of preserving Genentech’s very different company culture - which in the course of its prior 19 year collaboration produced Roche’s best selling biologics - the path for this merger did not run smoothly and the deal presented many very real challenges.
Join Dan Zabrowski and James Sabry, the key deal makers behind the merger at BioBusiness London, January 31st to February 2nd in London and hear a behind the scenes 2 year deal appraisal moderated by Simon Haworth from BSG Team Ventures. This intimate Q&A will be conducted off-the-record , with no PowerPoint slides, and will feature insight you won’t receive anywhere else, covering :
- Developing a new view the partnering perspective
- Anatomy of a mega-merger
- To license or acquire ?
- Deciding business model supports the science
- Retaining and enhancing the strengths from each partner
- Supporting individual scientific enterprise
- Fostering a semiautonomous centre for early drug development research
- Engaging both R&D organisations collaboratively
- Absorbing what makes biotech a success into an established pharma
- What are the challenges now given the joint culture ?
- What worked, what didn’t work
- What positive paradigm shifts have occurred as a result
- Measuring the success - how did we do ?
- Implications for future mergers, alliances and partnering
About BioBusiness - the European bio-partnering conference which places strategy at its core
BioBusiness 2012 is the only place in London where senior professionals, VP to CEO level delegates from small biotech’s through to top 10 pharma’s and key financers and advisors behind innovation will gather to discuss high level strategy and build quality relationships. This event is where forward thinking companies will come to make their next big deal.
Why BioBusiness is Different from other European bio-partnering conferences
BioBusiness isn’t your typical frenzied partnering meeting with a huge exhibition, covering everything under the sun ; only the most pertinent issues having an impact on your strategies will be discussed. Most importantly, the real decision makers will be there, and you’ll have quality, face-to-face time with people that matter.
Request the conference programme
Click here if you are a pharma executive ?
Click here if you are an innovative Biotech C-level executive
Click here if you are financing the innovation
BioBusiness offers :
cheack250 + VP to CEO level delegates
cheack65 + industry thought-leaders
cheack30 + sessions
cheack6 + off-the-record case studies and deal analyses
ONE EVENT where you can meet key decision makers in one place in London
